Exagen, Inc. (XGN)
4.98
-0.10
(-1.97%)
USD |
NASDAQ |
May 29, 16:00
4.99
+0.01
(+0.20%)
After-Hours: 20:00
Exagen EPS Diluted (Quarterly) : -0.1663 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.3639 |
| BioRestorative Therapies, Inc. | -0.1215 |
| CareDx, Inc. | 0.0529 |
| Natera, Inc. | -0.6013 |
| Sera Prognostics, Inc. | -0.1671 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.967M |
| Revenue (Quarterly) | 17.31M |
| Total Expenses (Quarterly) | 21.27M |
| Enterprise Value | 125.95M |
| Gross Profit Margin (Quarterly) | 58.97% |
| Profit Margin (Quarterly) | -22.92% |
| Earnings Yield | -17.75% |
| Normalized Earnings Yield | -16.69 |